Merck KGaA Consumer Health Builds “Horsepower”
This article was originally published in The Tan Sheet
Executive Summary
A transformation of the business unit that began two years ago is “fully on track and horsepower is increasing,” the company’s CFO reports during a third-quarter earnings call.
You may also be interested in...
Merck KGaA Moves Neurobion, Floratil Brands To Consumer Division
As of Jan. 1, the German firm moved Neurobion products, marketed globally, and the Floratil line sold in Brazil from Merck Serono to its Consumer Health division. The firm’s 2013 fourth quarter OTC and nutritional product sales were flat at $655 million
Merck KGaA Moves Neurobion, Floratil Brands To Consumer Division
As of Jan. 1, the German firm moved Neurobion products, marketed globally, and the Floratil line sold in Brazil from Merck Serono to its Consumer Health division. The firm’s 2013 fourth quarter OTC and nutritional product sales were flat at $655 million
Merck KGaA Appoints Novartis, J&J Veteran As Consumer Division Head
Merck KGaA appoints a pharma industry veteran without OTC sector experience, Udit Batra, to head its Consumer Health Care unit.